Gupta, Ashim
Maffulli, Nicola
Rodriguez, Hugo C.
Lee, Cassidy E.
Levy, Howard J.
El-Amin, Saadiq F. III http://orcid.org/0000-0001-9316-3172
Funding for this research was provided by:
BioIntegrate Inc. (Not applicable)
Article History
Received: 1 February 2021
Accepted: 10 February 2021
First Online: 18 February 2021
Ethics approval and consent to participate
: The study is registered in ClinicalTrials.gov; Identifier: NCT04719793; URL: ExternalRef removed. Ethics approval for this study was obtained from the South Texas Orthopaedic Research Institute–Institutional Review Board on 2 December 2020 (IRB unique identifier: STORI12022020-3; Study number: STORI12022020-3). This study is version 1.0, dated 14 October 2020. Date of recruitment is expected on 1 April 2021 and will be completed on 31 July 2022.The results from this study will be disseminated through manuscript publication in peer-reviewed journal and conference presentations at regional, national, and international platforms.
: Not applicable; no personally identifiable information will be published.
: AG is a consultant for BioIntegrate. HJL and SFE own equity in BioIntegrate. The remaining authors declare that they have no competing interests.